Trials / Completed
CompletedNCT02344563
Bioequivalence of Two Formulations of Meropenem Intravenous Injection
A Randomized, Single-dose, Two-way Crossover Study to Evaluate Bioequivalence of Two Formulations of Meropenem In Healthy Volunteers(Meropenem Intravenous Injection) After Intravenous Infusion
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Yung Shin Pharm. Ind. Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of meropenem (meropenem intravenous injection 0.5 g) after intravenous infusion in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meropem | |
| DRUG | Mepem |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-09-01
- Completion
- 2014-12-01
- First posted
- 2015-01-26
- Last updated
- 2015-01-26
Source: ClinicalTrials.gov record NCT02344563. Inclusion in this directory is not an endorsement.